Advisory Panel Backs Expanded Indications for CRT-D Devices

The FDA Circulatory System Devices Panel of the Medical Devices Advisory Committee today voted and recommended approval of expanded indications for all commercially available Medtronic cardiac resynchronization therapy defibrillator devices in patients with milder symptoms.
Cardiology Today